We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

BRCA1 tumour suppression occurs via heterochromatin-mediated silencing.

Nature | Sep 7, 2011

Mutations in the tumour suppressor gene BRCA1 lead to breast and/or ovarian cancer. Here we show that loss of Brca1 in mice results in transcriptional de-repression of the tandemly repeated satellite DNA. Brca1 deficiency is accompanied by a reduction of condensed DNA regions in the genome and loss of ubiquitylation of histone H2A at satellite repeats. BRCA1 binds to satellite DNA regions and ubiquitylates H2A in vivo. Ectopic expression of H2A fused to ubiquitin reverses the effects of BRCA1 loss, indicating that BRCA1 maintains heterochromatin structure via ubiquitylation of histone H2A. Satellite DNA de-repression was also observed in mouse and human BRCA1-deficient breast cancers. Ectopic expression of satellite DNA can phenocopy BRCA1 loss in centrosome amplification, cell-cycle checkpoint defects, DNA damage and genomic instability. We propose that the role of BRCA1 in maintaining global heterochromatin integrity accounts for many of its tumour suppressor functions.

Pubmed ID: 21901007 RIS Download

Mesh terms: Animals | BRCA1 Protein | Breast | Breast Neoplasms | Cell Line, Tumor | Cells, Cultured | DNA, Satellite | Epithelial Cells | Female | Gene Expression Regulation, Neoplastic | Gene Silencing | Genes, BRCA1 | Genomic Instability | HeLa Cells | Heterochromatin | Histones | Humans | Mice | Ovarian Neoplasms | RNA, Messenger | Transcription, Genetic | Ubiquitin-Protein Ligases | Ubiquitinated Proteins | Ubiquitination

Research tools detected in this publication

None found

Data used in this publication

Associated grants

  • Agency: NINDS NIH HHS, Id: R01 NS050217-05
  • Agency: NINDS NIH HHS, Id: NS50217
  • Agency: NINDS NIH HHS, Id: R01 NS052842-04
  • Agency: NINDS NIH HHS, Id: R01 NS050217
  • Agency: NINDS NIH HHS, Id: R01 NS052842
  • Agency: NINDS NIH HHS, Id: NS52842

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.